CEACAM5 and neoplasm: In addition, a 790-gene custom Nanostring panel based on microdissected tumor specimens at baseline and following one treatment dose was used to investigate tumor molecular signatures predictive of viral replication and the effect of viral treatment on tumor expression profiling of patients with GBM treated with MV-CEA.